Immunity to alpha-Gal: Toward a Single-Antigen Pan-Vaccine To Control Major Infectious Diseases

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60077344%3A_____%2F17%3A00483962" target="_blank" >RIV/60077344:_____/17:00483962 - isvavai.cz</a>
Result on the web
<a href="https://pubs.acs.org/doi/10.1021/acscentsci.7b00517" target="_blank" >https://pubs.acs.org/doi/10.1021/acscentsci.7b00517</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Immunity to alpha-Gal: Toward a Single-Antigen Pan-Vaccine To Control Major Infectious Diseases
Original language description
Infectious diseases constitute a growing burden for human health worldwide. In particular, vector-borne diseases account for 17% of all infectious diseases and kill about 1 million people annually.1 These diseases are caused by a diverse group of pathogens including viruses, bacteria, and protozoa that are transmitted by arthropod vectors such as ticks, mosquitoes, sandflies, kissing bugs, and tsetse flies.1 Among the nonviral vector-borne diseases, malaria, leishmaniasis, Chagas disease, sleeping sickness, and Lyme disease represent the highest burden to human health. Further, vaccines are not available for the prevention and control of these diseases.2 Among non-vector-borne diseases, tuberculosis caused by mycobacteria of the Mycobacterium tuberculosis complex is one of the world’s most common causes of death from infectious diseases.
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)